James Talarico teams with Mark Cuban on new healthcare ‘monopolies’ plan
Texas Senate candidate James Talarico (D-TX) speaks at a campaign rally on March 2, 2026 in Houston, Texas.…
We’re increasing our Eli Lilly price target after another beat-and-raise quarter
Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…
States look to drop prescription costs by reining in middlemen
TOPEKA, Kan. (AP) — As consumers worry about medication costs, states are trying to lower drug prices by…
CVS Returns Zepbound to Drug Plans After Lilly Slashes Price
More than 10 million US patients will regain easy access to Eli Lilly & Co.’s obesity shot Zepbound…
18. Thyme Care
Founders: Robin Shah (CEO), Bobby GreenLaunched: 2020Headquarters: Nashville, TennesseeFunding: $235 millionValuation: N/AKey Technologies: N/AIndustry: HealthcarePrevious appearances on Disruptor…
CVS Health (CVS) earnings Q1 2026
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24,…
Stitch Fix, apparel retailers may benefit
Michelle Suter has worn mostly big and baggy clothing for years. The 63-year-old retiree who lives in a…
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
Eli Lilly’s lead in the obesity race gets wider after win against Novo
In the lucrative obesity drug race, there is Eli Lilly — and then there’s everybody else. A pair…
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
Eli Lilly launches Zepbound obesity drug pen with one month of doses
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March…